Scholarlink

<p>Typhoid fever continues to pose significant public health burden due to the declining efficacy of the current medications, prompting the demand for more effective and newer antibiotics. Herein, in silico drug design techniques including, genetic function approximation based QSAR modeling, molecular docking simulation using <i>PyRx</i> 8.0, druglikeness evaluation using Lipinski’s and Veber’s rules, and pharmacokinetic/toxicity profiling were integrated to investigate the observed anti-<i>Salmonella enterica</i> properties of some indole-1,2,4 triazole conjugates. An optimum tri-parametric QSAR model (R<sup>2</sup><sub>train</sub> = 0.806; R<sup>2</sup><sub>adj</sub> = 0.747; Q<sup>2</sup><sub>CV</sub> = 0.675; R<sup>2</sup><sub>test</sub> = 0.647) hints the predominant influence of molecular surface area on the observed antibacterial properties of the bioactive ligands. Ligand based optimization of ligand 9, the template molecule (Tm) yielded more potent analogues; D1, D2, D3, D4, D5, and D6. The designed ligands were found to bind more strongly to DNA gyrase of the bacteria with ∆G values that range from − 10.0 to -11.5&#xa0;kcal/mol when compared with Tm and a control drug, Ciprofloxacin (Cipro) which bind to the receptor with ∆G value of -9.6 and − 7.6&#xa0;kcal/mol, respectively. The high efficacies of the designed ligands are also supported by DFT-based quantum mechanical calculations. In addition, the new ligands display good pharmacokinetics and toxicity profiles. The outcome of this study positions these newly designed bioactive ligands as potential indole-1,2,4 triazole based antibiotics against typhoid fever and are strongly recommended for further in vitro and in vivo investigations.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Chemoinformatics-based discovery of new indole-1,2,4 triazole analogues with potential for the treatment of typhoid fever

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月10日

查看全文
  • Philip John Ameji,
  • Adamu Uzairu,
  • Gideon Adamu Shallangwa,
  • Sani Uba,
  • Muhammad Tukur Ibrahim

摘要

Typhoid fever continues to pose significant public health burden due to the declining efficacy of the current medications, prompting the demand for more effective and newer antibiotics. Herein, in silico drug design techniques including, genetic function approximation based QSAR modeling, molecular docking simulation using PyRx 8.0, druglikeness evaluation using Lipinski’s and Veber’s rules, and pharmacokinetic/toxicity profiling were integrated to investigate the observed anti-Salmonella enterica properties of some indole-1,2,4 triazole conjugates. An optimum tri-parametric QSAR model (R2train = 0.806; R2adj = 0.747; Q2CV = 0.675; R2test = 0.647) hints the predominant influence of molecular surface area on the observed antibacterial properties of the bioactive ligands. Ligand based optimization of ligand 9, the template molecule (Tm) yielded more potent analogues; D1, D2, D3, D4, D5, and D6. The designed ligands were found to bind more strongly to DNA gyrase of the bacteria with ∆G values that range from − 10.0 to -11.5 kcal/mol when compared with Tm and a control drug, Ciprofloxacin (Cipro) which bind to the receptor with ∆G value of -9.6 and − 7.6 kcal/mol, respectively. The high efficacies of the designed ligands are also supported by DFT-based quantum mechanical calculations. In addition, the new ligands display good pharmacokinetics and toxicity profiles. The outcome of this study positions these newly designed bioactive ligands as potential indole-1,2,4 triazole based antibiotics against typhoid fever and are strongly recommended for further in vitro and in vivo investigations.